Profluent Bio Inc.
AI-designed biological molecules and organisms for therapeutic and agricultural applications
- Sector
- Biotech
- Headquarters
- SAN FRANCISCO, CA
- Founded
- 2022
- Latest Form D
- $8M, Aug 2022
- Total capital
- $8M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $8M
- 1 Form D · last Aug 2022
- 50 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 11 pending · first 2024
- Rank in peer group#397 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$8M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#397 · top 27%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Ali MadaniResearcherExecutive Officer, DirectorLinked by 1 patent
- Dylan MorrisDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 13- New patentAdenine Deaminases And Compositions, Systems, And Methods ThereofUSPTOUS 12,747,436
- PendingAdenine Deaminases And Compositions, Systems, And Methods ThereofUSPTOApplication 19255359
- PendingNucleases And Compositions, Systems, And Methods ThereofUSPTOApplication 18921949
Show all 13 patent records
- Adenine Deaminases And Compositions, Systems, And Methods ThereofSep 29, 2026 · US 12,747,436Granted
- Adenine Deaminases And Compositions, Systems, And Methods ThereofOct 23, 2025 · Application 19255359Pending
- Nucleases And Compositions, Systems, And Methods ThereofJul 31, 2025 · Application 18921949Pending
- Nucleases And Compositions, Systems, And Methods ThereofOct 22, 2024 · US 12,123,016Granted
- Systems And Methods For Determining And Engineering Pam Specificity Of Cas ProteinsApplication 63739011Pending
- Adenine Deaminases And Compositions, Systems, And Methods ThereofApplication PCTUS2024056236Pending
- Systems And Methods For Determining And Engineering Pam Specificity Of Cas ProteinsApplication PCTUS2025061343Pending
- Systems And Methods For Protein DesignApplication 63678316Pending
- Nucleases And Compositions, Systems, And Methods ThereofApplication 63572751Pending
- Nucleases And Compositions, Systems, And Methods ThereofApplication 63627457Pending
- Adenine Deaminases And Compositions, Systems, And Methods ThereofApplication 63599141Pending
- Nucleases And Compositions, Systems, And Methods ThereofApplication PCTUS2025014132Pending
- Systems And Methods For Protein DesignApplication PCTUS2025040355Pending
Related companies, and why
- Xanadu Bio, Inc.Similar federal contract value in Biotech · null in contracts
- SINGULAR IMMUNE, INC.Similar federal contract value in Biotech · null in contracts
- ClostraBio, Inc.Similar federal contract value in Biotech · null in contracts
- TenSixty Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
- Inversion Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Arialys TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .